Home
Editorial
Services
Interview
Q&A
Chronicle Specials
Pharma Mart
ePharmail
Archives
Tenders & Project
Tenders & Enquiries
Pharma Projects
Corporate
Company Profiles
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
Join Pharma
|
Login
Home
>
News
you can get e-magazine links on WhatsApp.
Click here
News
Xilio Therapeutics initiates enrollment in phase 1 trial of tumour-activated, Fc-enhanced anti-CTLA-4, XTX101 in combo with atezolizumab
,
December 09, 2023
Bristol Myers Squibb announces phase 3 CheckMate -8HW trial of Opdivo plus Yervoy compared to chemotherapy in MSI-H or dMMR mCRC meets dual primary endpoint
,
December 09, 2023
Merck to discontinue phase 3 KEYLYNK-008 trial of Keytruda plus Lynparza to treat metastatic squamous NSCLC
,
December 09, 2023
Hansa Biopharma announces positive results from 15-HMedIdeS-09 phase 2 trial of imlifidase to treat Guillain-Barré syndrome
,
December 08, 2023
Sanofi announces phase 3 IMROZ trial of Sarclisa in combo with bortezomib, lenalidomide & dexamethasone meets primary endpoint of PFS in patients with newly diagnosed MM
,
December 08, 2023
Merck announces positive results from phase 2 KeyVibe-002 trial evaluating coformulation of vibostolimab and pembrolizumab in previously treated patients with metastatic NSCLC
,
December 08, 2023
Enveric selects development candidates from EVM301 Series based on potential to minimize or eliminate the hallucinogenic effect of psychedelic-derived compounds
,
December 07, 2023
NIH-supported study shows surgery beneficial for some children with mild sleep-disordered breathing
,
December 07, 2023
Exelixis initiates STELLAR-305 phase 2/3 pivotal trial of zanzalintinib in combo with pembrolizumab in patients with previously untreated recurrent or metastatic SCCHN
,
December 06, 2023
Roche announces positive results from phase III INAVO120 study of inavolisib combination in people with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation
,
December 06, 2023
UK MHRA grants CTA for Mission Therapeutics to begin phase 1 study of MTX325 to treat Parkinson’s disease
,
December 06, 2023
Exelixis, Arcus Biosciences enter clinical trial collaboration to evaluate zanzalintinib in combo with AB521 in patients with advanced RCC
,
December 05, 2023
Sana Biotechnology announces early clinical data of SC291, a CD19-directed allogeneic CAR T cell therapy
,
December 05, 2023
Foghorn Therapeutics to present clinical data from phase 1 study of FHD-286 at ASH Annual Meeting in San Diego
,
December 05, 2023
Telix begins patient dosing in Netherlands for PET imaging agent, TLX250-CDx to treat kidney cancer
,
December 05, 2023
SciSparc's obesity drug showed positive results in a pre-clinical trial
,
December 04, 2023
Pfizer reports positive results from phase 2b trial of oral GLP-1R agonist, danuglipron in adults with obesity
,
December 04, 2023
Daiichi Sankyo demonstrates breadth and depth of oncology portfolio across multiple cancers with new data at ESMO Asia, SABCS & ASH
,
December 02, 2023
First WHO Global Clinical Trials Forum puts forward a global vision for sustainable clinical research infrastructure
,
December 02, 2023
AstraZeneca to discontinue STABILIZE-CKD and DIALIZE-Outcomes phase III trials for Lokelma
,
December 02, 2023
Results Found:
15052
1
2
3
4
5
Go to
Total Number of Pages:
753
Loading...
Close
Open
Copyright © 2023 Saffron Media Pvt. Ltd |
About us
|
Contact us
|
Advertise
|
Feedback
|
Helpdesk
|
Disclaimer
|
Sitemap
|
Archives